INTEGRATED BIOPHARMA INC Common Stock Shares Outstanding

Quick Answer

INTEGRATED BIOPHARMA INC reported Common Stock Shares Outstanding of 31.06 million shares for the year ending 2025.

  • INTEGRATED BIOPHARMA INC showed an increase of +3.2% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from INTEGRATED BIOPHARMA INC's annual report (Form 10-K), filed with the SEC on September 23, 2025.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q4 2011: 20.98 million shares | Q1 2012: 21.03 million shares | Q3 2012: 21.12 million shares | Q4 2012: 21.12 million shares | Q1 2013: 21.12 million shares | Q3 2013: 21.12 million shares | Q1 2014: 21.12 million shares | Q3 2014: 21.11 million shares | Q4 2014: 21.14 million shares | Q1 2015: 21.11 million shares | Q2 2015: 21.11 million shares | Q3 2015: 21.11 million shares | Q4 2015: 21.11 million shares | Q1 2016: 21.14 million shares | Q3 2016: 21.11 million shares | Q4 2016: 21.11 million shares | Q1 2017: 21.13 million shares | Q3 2017: 21.17 million shares | Q4 2017: 21.17 million shares | Q1 2018: 21.17 million shares | Q3 2018: 29.37 million shares | Q4 2018: 29.57 million shares | Q3 2019: 29.57 million shares | Q4 2019: 29.57 million shares | Q1 2020: 29.57 million shares | Q3 2020: 29.65 million shares | Q4 2020: 29.68 million shares | Q1 2021: 29.75 million shares | Q3 2021: 29.82 million shares | Q4 2021: 29.83 million shares | Q1 2022: 29.83 million shares | Q3 2022: 29.95 million shares | Q4 2022: 29.95 million shares | Q1 2023: 29.95 million shares | Q3 2023: 30.10 million shares | Q4 2023: 30.10 million shares | Q1 2024: 30.10 million shares | Q3 2024: 30.13 million shares | Q4 2024: 30.30 million shares | Q1 2025: 30.30 million shares | Q2 2025: 31.06 million shares | Q3 2025: 31.06 million shares | Q4 2025: 31.09 million shares.
  • Over the full 15 years of available data (2011 to 2025), INTEGRATED BIOPHARMA INC's Common Stock Shares Outstanding has grown by 48.8%.
  • Historical annual values: Fiscal year 2025: 31.06 million shares | Fiscal year 2024: 30.10 million shares | Fiscal year 2023: 29.95 million shares | Fiscal year 2022: 29.95 million shares | Fiscal year 2021: 29.80 million shares | Fiscal year 2020: 29.65 million shares | Fiscal year 2019: 29.57 million shares | Fiscal year 2018: 21.14 million shares | Fiscal year 2017: 21.14 million shares | Fiscal year 2016: 21.11 million shares | Fiscal year 2015: 21.11 million shares | Fiscal year 2014: 21.11 million shares | Fiscal year 2013: 21.08 million shares | Fiscal year 2012: 21.08 million shares | Fiscal year 2011: 20.88 million shares.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: